Van ECK Associates Corp Grows Position in Ventas, Inc. $VTR

Van ECK Associates Corp increased its stake in shares of Ventas, Inc. (NYSE:VTR) by 12.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 243,156 shares of the real estate investment trust’s stock after acquiring an additional 27,590 shares during the quarter. Van ECK Associates Corp’s holdings in Ventas were worth $17,018,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Bank of Montreal Can boosted its holdings in shares of Ventas by 22.1% during the 3rd quarter. Bank of Montreal Can now owns 377,964 shares of the real estate investment trust’s stock valued at $26,454,000 after purchasing an additional 68,450 shares during the last quarter. Schroder Investment Management Group increased its holdings in shares of Ventas by 3.6% in the third quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust’s stock worth $170,946,000 after purchasing an additional 85,340 shares during the last quarter. Inceptionr LLC purchased a new stake in shares of Ventas in the third quarter worth about $1,677,000. Parallel Advisors LLC boosted its stake in Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after buying an additional 175 shares during the last quarter. Finally, Meiji Yasuda Life Insurance Co bought a new position in Ventas during the third quarter valued at approximately $208,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

VTR has been the topic of a number of research reports. Wells Fargo & Company lifted their price objective on Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Jefferies Financial Group reissued a “buy” rating and issued a $93.00 target price on shares of Ventas in a report on Monday, December 15th. Royal Bank Of Canada boosted their price target on shares of Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 10th. UBS Group reaffirmed a “neutral” rating and set a $85.00 price target on shares of Ventas in a research note on Monday, February 9th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 price objective on shares of Ventas in a research report on Monday, February 9th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $89.00.

Insider Transactions at Ventas

In related news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This represents a 0.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Robert F. Probst sold 29,930 shares of the firm’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the sale, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at approximately $10,694,026.50. The trade was a 17.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 86,106 shares of company stock worth $6,931,397. 0.80% of the stock is currently owned by insiders.

Ventas Trading Up 0.5%

Shares of NYSE:VTR traded up $0.45 during trading on Friday, hitting $86.65. The company had a trading volume of 721,015 shares, compared to its average volume of 2,861,053. The stock has a market cap of $41.15 billion, a price-to-earnings ratio of 160.59, a price-to-earnings-growth ratio of 2.09 and a beta of 0.73. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The company has a fifty day simple moving average of $81.27 and a two-hundred day simple moving average of $76.19. Ventas, Inc. has a one year low of $60.15 and a one year high of $87.87.

Ventas (NYSE:VTR) last released its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The company had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities analysts forecast that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a $0.52 dividend. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s payout ratio is currently 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.